112 related articles for article (PubMed ID: 11532018)
21. IFN-gamma suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor.
Huang Z; Xin J; Coleman J; Huang H
J Immunol; 2005 Feb; 174(3):1332-7. PubMed ID: 15661890
[TBL] [Abstract][Full Text] [Related]
22. Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription.
Shen CH; Stavnezer J
Mol Cell Biol; 1998 Jun; 18(6):3395-404. PubMed ID: 9584180
[TBL] [Abstract][Full Text] [Related]
23. STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.
Gooch JL; Christy B; Yee D
Neoplasia; 2002; 4(4):324-31. PubMed ID: 12082548
[TBL] [Abstract][Full Text] [Related]
24. Stat5 activation plays a critical role in Th2 differentiation.
Zhu J; Cote-Sierra J; Guo L; Paul WE
Immunity; 2003 Nov; 19(5):739-48. PubMed ID: 14614860
[TBL] [Abstract][Full Text] [Related]
25. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
[TBL] [Abstract][Full Text] [Related]
26. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation.
Venkataraman C; Leung S; Salvekar A; Mano H; Schindler U
J Immunol; 1999 Apr; 162(7):4053-61. PubMed ID: 10201928
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the dephosphorylation of Stat6. Participation of Tyr-713 in the interleukin-4 receptor alpha, the tyrosine phosphatase SHP-1, and the proteasome.
Hanson EM; Dickensheets H; Qu CK; Donnelly RP; Keegan AD
J Biol Chem; 2003 Feb; 278(6):3903-11. PubMed ID: 12459556
[TBL] [Abstract][Full Text] [Related]
28. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-gamma activation site.
Karras JG; Wang Z; Coniglio SJ; Frank DA; Rothstein TL
J Immunol; 1996 Jul; 157(1):39-47. PubMed ID: 8683142
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma inhibits STAT6 signal transduction and gene expression in human airway epithelial cells.
Heller NM; Matsukura S; Georas SN; Boothby MR; Rothman PB; Stellato C; Schleimer RP
Am J Respir Cell Mol Biol; 2004 Nov; 31(5):573-82. PubMed ID: 15297269
[TBL] [Abstract][Full Text] [Related]
30. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
31. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
32. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
33. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
David M; Ford D; Bertoglio J; Maizel AL; Pierre J
Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
[TBL] [Abstract][Full Text] [Related]
34. A conditionally active form of STAT6 can mimic certain effects of IL-4.
Kamogawa Y; Lee HJ; Johnston JA; McMahon M; O'Garra A; Arai N
J Immunol; 1998 Aug; 161(3):1074-7. PubMed ID: 9686563
[TBL] [Abstract][Full Text] [Related]
35. Cytokine transcriptional events during helper T cell subset differentiation.
Lederer JA; Perez VL; DesRoches L; Kim SM; Abbas AK; Lichtman AH
J Exp Med; 1996 Aug; 184(2):397-406. PubMed ID: 8760793
[TBL] [Abstract][Full Text] [Related]
36. Activation of STAT6 is not dependent on phosphotyrosine-mediated docking to the interleukin-4 receptor and can be blocked by dominant-negative mutants of both receptor subunits.
Moriggl R; Erhardt I; Kammer W; Berchtold S; Schnarr B; Lischke A; Groner B; Friedrich K
Eur J Biochem; 1998 Jan; 251(1-2):25-35. PubMed ID: 9492265
[TBL] [Abstract][Full Text] [Related]
37. The transcriptional co-activator p/CIP (NCoA-3) is up-regulated by STAT6 and serves as a positive regulator of transcriptional activation by STAT6.
Arimura A; vn Peer M; Schröder AJ; Rothman PB
J Biol Chem; 2004 Jul; 279(30):31105-12. PubMed ID: 15145939
[TBL] [Abstract][Full Text] [Related]
38. HTLV-1 cell lines differ in constitutively activated signaling pathways that can be altered by cytokine exposure.
Liang W; Hague B; Zhao T; Kindt TJ
Virology; 2001 Nov; 290(1):91-8. PubMed ID: 11883009
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production.
Siemasko K; Chong AS; Jäck HM; Gong H; Williams JW; Finnegan A
J Immunol; 1998 Feb; 160(4):1581-8. PubMed ID: 9469413
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor.
Ryan JJ; McReynolds LJ; Huang H; Nelms K; Paul WE
J Immunol; 1998 Aug; 161(4):1811-21. PubMed ID: 9712048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
